New reference for JEMA in Medical application

Last August Jema was awarded with a new order for two High Voltage Power Supplies (HVPS) from the Belgium company IBA.These new HVPS will be used in a new machine for the production of radioisotopes (Mo-99) that will be used in the diagnose of heart disease, cancer, infection, etc.

The scope of supply is 2 HVPS, 22 kV 150 A pulsed tetrode with a maximum output power of 3.3 MW and an average power of 462 KW.

The final product is the Rhodotron® TT300 HE electron accelerators for U.S. production of the radioisotope molybdenum-99 (Mo-99), which in turn is used to produce the important diagnostic imaging radioisotope technetium-99m (Tc-99m). The Tc-99m radioisotope and Tc-99m-based radiopharmaceuticals are the most common radioisotopes used to diagnose and stage heart disease, cancer, infection, inflammation and other conditions.

This devices will be located in the state of Wisconsin , USA.

This new reference offers the possibility to JEMA to contribute in the modern medicine treatment ,improving the quality of life of thepatients.

 

About IBA

IBA is the world leader in proton therapy solutions for the cancer treatment. The industrial part of this company, for whom this HVPS are, provides equipment for Medical Device Sterilization, X-rays, etc.